Indication-Based Pricing (IBP)

As more and more medicines come to market with multiple indications or the unrealised potential to treat multiple indications, the way we pay for those medicines becomes critical in making sure we can benefit from them. Indication-based pricing (IBP) permits price to vary according to indication and has been proposed to tackle this issue.

Featured

Filter results by

Theme
Tag
Date
Author
Content Type
No posts found